Icosavax(NASDAQ:ICVX) 
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-A12, an respiratory syncytial ...
Website: https://icosavax.com/
Founded: 2017
CEO: Adam Simpson
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-08-22
P
O 7.54
H 7.90
L 7.44
C 7.79
V 284,981
10EMA 7.79
20EMA 7.79
60EMA 7.79
120EMA 7.79
250EMA 7.79